Alpha‐amylase as molecular target for treatment of diabetes mellitus: A comprehensive review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Alpha‐amylase as molecular target for treatment of diabetes mellitus: A comprehensive review
Authors
Keywords
-
Journal
Chemical Biology & Drug Design
Volume 98, Issue 4, Pages 539-560
Publisher
Wiley
Online
2021-06-26
DOI
10.1111/cbdd.13909
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis of Some New Pyrazolone‐Based Heterocycles Containing Sulphone Moiety Acting as α‐Glucosidase and α‐Amylase Inhibitors
- (2019) Taha M. A. Eldebss et al. JOURNAL OF HETEROCYCLIC CHEMISTRY
- Evaluation of a flavonoids library for inhibition of pancreatic α-amylase towards a structure–activity relationship
- (2019) Carina Proença et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Antidiabetic and Antihyperlipidemic Activities of the Leaf Latex Extract of Aloe megalacantha Baker (Aloaceae) in Streptozotocin-Induced Diabetic Model
- (2019) Workineh Woldeselassie Hammeso et al. Evidence-based Complementary and Alternative Medicine
- Spiroindolone Analogues as Potential Hypoglycemic with Dual Inhibitory Activity on α-Amylase and α-Glucosidase
- (2019) Mezna Saleh Altowyan et al. MOLECULES
- In vitro α-amylase inhibitory effect of TLC isolates of Aloe megalacantha baker and Aloe monticola Reynolds
- (2019) Gebretsadkan Hintsa Tekulu et al. BMC Complementary and Alternative Medicine
- Synthesis and molecular docking studies of imines as α-glucosidase and α-amylase inhibitors
- (2019) Analy Aispuro-Pérez et al. BIOORGANIC CHEMISTRY
- Synthesis of benzotriazoles derivatives and their dual potential as α-amylase and α-glucosidase inhibitors in vitro: Structure-activity relationship, molecular docking, and kinetic studies
- (2019) Shehryar Hameed et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, molecular docking and QSAR study of thiazole clubbed pyrazole hybrid as α-amylase inhibitor
- (2019) Meenakshi Duhan et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Synthesis, crystal structures, computational studies and α-amylase inhibition of three novel 1,3,4-oxadiazole derivatives
- (2019) Syeda Shamila Hamdani et al. JOURNAL OF MOLECULAR STRUCTURE
- G-protein-coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives
- (2018) Guido Sebastiani et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Free fatty acid receptor 1 as a novel therapeutic target for type 2 diabetes mellitus-current status
- (2018) Chinedum Eleazu et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Neonatal Diabetes Mellitus
- (2018) Michelle Blanco Lemelman et al. CLINICS IN PERINATOLOGY
- 2ʹ-Aryl and 4ʹ-arylidene substituted pyrazolones: As potential α-amylase inhibitors
- (2018) Sahar Yousuf et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of α-amylase by flavonoids: Structure activity relationship (SAR)
- (2018) A.I. Martinez-Gonzalez et al. SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
- Design, and facile synthesis of 1,3 diaryl-3-(arylamino)propan-1-one derivatives as the potential alpha-amylase inhibitors and antioxidants
- (2018) Roqia Bashary et al. BIOORGANIC CHEMISTRY
- Fructose-1,6-bisphosphatase inhibitors: A new valid approach for management of type 2 diabetes mellitus
- (2017) Ramandeep Kaur et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Acteoside and Acyl-Migrated Acteoside, Compounds in Chinese Kudingcha Tea, Inhibit α-Amylase In Vitro
- (2017) Yuqin Lu et al. JOURNAL OF MEDICINAL FOOD
- Synthesis of novel inhibitors of α-amylase based on the thiazolidine-4-one skeleton containing a pyrazole moiety and their configurational studies
- (2017) Parvin Kumar et al. MedChemComm
- Salivary Amylase: Digestion and Metabolic Syndrome
- (2016) Catherine Peyrot des Gachons et al. Current Diabetes Reports
- Prevalence and comorbidities of double diabetes
- (2016) S.R. Merger et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Glucagon is the key factor in the development of diabetes
- (2016) Young H. Lee et al. DIABETOLOGIA
- Influence of gallic acid on α-amylase and α-glucosidase inhibitory properties of acarbose
- (2016) Ganiyu Oboh et al. JOURNAL OF FOOD AND DRUG ANALYSIS
- α-Glucosidase and α-Amylase Inhibitors from Arcytophyllum thymifolium
- (2016) Luigi Milella et al. JOURNAL OF NATURAL PRODUCTS
- Inhibitory effect of 4,4′-[ethane-1,2-diylbis(sulfandiylmethanediyl)]bis(3,5-dimethyl-1H-pyrazole) and its derivatives on alpha-amylase activity
- (2016) Vadim Maksimov et al. MEDICINAL CHEMISTRY RESEARCH
- α-Amylase Inhibitors: A Review of Raw Material and Isolated Compounds from Plant Source
- (2016) Paloma Michelle Sales et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Glycogen Phosphorylase as a Target for Type 2 Diabetes: Synthetic, Biochemical, Structural and Computational Evaluation of Novel N-acyl-N´-(β-D-glucopyranosyl) Urea Inhibitors
- (2015) Anastassia Kantsadi et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Sodium-Glucose Co-Transporter 2 Inhibition in Diabetes Treatment: Current Evidence and Future Perspectives
- (2014) Evangelos Rizos et al. CURRENT PHARMACEUTICAL DESIGN
- Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment
- (2013) Jessica L. Hwang et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Anti-Hyperglycemic Effect ofVaccinium arctostaphylosin Type 2 Diabetic Patients: A Randomized Controlled Trial
- (2013) Saeed Kianbakht et al. FORSCHENDE KOMPLEMENTARMEDIZIN
- Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Agonists on Glycemic Control, Lipid Profile and Cardiovascular Risk
- (2012) Giuseppe Derosa et al. Current Molecular Pharmacology
- Potent α-amylase inhibitory activity of Indian Ayurvedic medicinal plants
- (2011) Sudha P et al. BMC Complementary and Alternative Medicine
- Impact of Calcium on Salivary α-Amylase Activity, Starch Paste Apparent Viscosity, and Thickness Perception
- (2011) Cecile Morris et al. Chemosensory Perception
- Human α-amylase and starch digestion: An interesting marriage
- (2011) Peter J. Butterworth et al. STARCH-STARKE
- Structures of human pancreatic α-amylase in complex with acarviostatins: Implications for drug design against type II diabetes
- (2010) Xiaohong Qin et al. JOURNAL OF STRUCTURAL BIOLOGY
- The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents
- (2010) Sonia Tucci Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Taxonomy of theStreptomycesstrain ZG0656 that produces acarviostatin α-amylase inhibitors and analysis of their effects on blood glucose levels in mammalian systems
- (2008) P. Geng et al. JOURNAL OF APPLIED MICROBIOLOGY
- Flavonoids for Controlling Starch Digestion: Structural Requirements for Inhibiting Human α-Amylase
- (2008) Elena Lo Piparo et al. JOURNAL OF MEDICINAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started